About
TCT Saglik – Transforming Future of Medicine
Türkiye Cell Therapies
At TCT Saglik, we are pioneering next-generation cell and gene therapies to revolutionize the future of medicine. We aim to bring biotechnology solutions to Türkiye through technology transfer, strategic collaborations, licensing aggrements and local innovation.
We specialize in CAR-T therapy, cell-based treatments, and advanced biopharmaceutical solutions, working alongside global industry leaders like AbClon and Cytiva to accelerate the development, licensing and commercialization of innovative treatments.
Through our commitment to R&D, clinical advancements, and high-quality manufacturing, we aim to establish Türkiye as a key biotechnology hub, ensuring that transformative treatments reach patients faster and more efficiently.
Join us as we push the boundaries of science, create breakthrough therapies, and shape the future of personalized medicine.
TCT Saglik
Advancing Science, Delivering Hope.
Details
- Tagline:
- TCT advances biotechnology with innovative healthcare solutions, focusing on cell and gene therapies to transform care
- Industry:
- Biotechnology Research
- Company size:
- 11-50
- Headquarters:
- Istanbul
- Ümraniye
- Org type:
- Privately Held
- Founded:
- 2024
- Specialties:
- health, cellandgenetherapies, and treatments
- Follower count:
- 752
- Employee count:
- 6
